Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Krishan L. Gupta
CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
Kidney International Reports
Nephrology
Related publications
Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy; An Indian Experience
Journal of Renal Injury Prevention
Urology
Nephrology
Anti-Phospholipase A2 Receptor Antibody Positive Hepatitis B Virus-Associated Membranous Nephropathy Remitted With Entecavir After Relapse With Lamivudine
Journal of Nephropathology
Nephrology
Variants of M-Type Phospholipase A2 Receptor (PLA2R1) Gene Associated With Susceptibility to Idiopathic Membranous Nephropathy (IMN)
Clinical pharmacology and therapy
IgG4-Related Disease Is Not Associated With Antibody to the Phospholipase A2 Receptor
International Journal of Rheumatology
Rheumatology
Immunology
Association of Phospholipase A2 Receptor 1 Polymorphisms With Idiopathic Membranous Nephropathy in Chinese Patients in Taiwan
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Relationship Between Renal Tissues Phospholipase A2 Receptor and Its Serum Antibody and Clinical Condition and Prognosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
BMC Nephrology
Nephrology
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
Kidney International Reports
Nephrology
Efficacy and Safety of Rituximab in Hepatitis-B Virus-Associated PLA2R-positive Membranous Nephropathy
Kidney International Reports
Nephrology
Non-Ischemic Cardiomyopathy After Rituximab Treatment for Membranous Nephropathy
Journal of Renal Injury Prevention
Urology
Nephrology
